Mega Lifesciences Public Company Limited (MEGA.BK)

39.75 0.00 (0.00%) At close: 04:35PM ICT

Mega Lifesciences Public Company Limited

909, Ample Tower
9th floor Debaratna Road Bangna Nuea, Bangna
Bangkok 10260
Thailand
66 2 769 4222
https://www.megawecare.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Vivek Dhawan	CEO, Chief Coach & Executive Director	N/A	N/A	1961
Mr. Thomas Abraham	CFO & Executive Director	N/A	N/A	1963
Mr. Deepak Panjwani	Chief Risk & Compliance Officer	N/A	N/A	1974
Mr. Paramjit Singh Sawhney	President of International	N/A	N/A	1963
Mr. Girish Wadhwa	President of Myanmar	N/A	N/A	1970
Mr. Manoj Gurbuxani	Deputy Chief Financial Officer	N/A	N/A	1974
Ms. Duangnapa Tongsiri	President of Mega We Care Thailand	N/A	N/A	1960
Ms. Sujintana Boonworapat	Corporate Secretary	N/A	N/A	1972

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in THB.

Description

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids', men's, and women's care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, as well as involved in the software design, development, and other services business. The company was founded in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.

Corporate Governance

Mega Lifesciences Public Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.